Navari closes latest investment round
Funding accelerates AR platform for tumor visualization in surgery. Thanks Chalmers Ventures, Almi Invest Väst, GU Ventures, First Gate Invest, and angels. Clinical study planned for 2026.
See the latest news and media coverage for Navari. We track all announcements, press releases, and industry mentions in real time, all in one place.
Augmented reality guidance for cancer surgery
navarisurgical.comLast updated
In short: Navari received regulatory approval to begin first-in-human clinical trials for its AI and AR-powered surgical navigation platform.
Funding accelerates AR platform for tumor visualization in surgery. Thanks Chalmers Ventures, Almi Invest Väst, GU Ventures, First Gate Invest, and angels. Clinical study planned for 2026.
The grant supports finalizing the product for validation, a clinical study, and initial market launch steps. It comes from Vinnova’s deeptech acceleration call.
The study involved 6 liver surgeries guided by Navari technology over two weeks, achieving proof-of-concept in vivo.
The company is awarded 75,000 EUR plus mentoring and coaching under the EIC women leadership programme.
The public Navarre research center Navarrabiomed positions itself as a key engine in the biosanitary industry thanks to its advances in...
Surgeons often struggle to accurately locate and remove tumours using conventional surgical cameras, which provide a limited field of view. This increases the risk of...
Track Navari and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.